Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tumor Necrosis Factor Receptor Type 2 (TNFR2) is a type I transmembrane protein and a member of the tumor necrosis factor receptor superfamily. It is one of two main receptors for TNFα. TNFR2 plays a role in immune regulation, tissue protection, and can have both pro-inflammatory and anti-inflammatory effects depending on the context. It is highly expressed on myeloid cells, Tregs, and some T-cell/B-cell subsets. TNFR2 is being investigated as a therapeutic target in cancer immunotherapy and autoimmune diseases.
Agonism or antagonism of TNFR2 signaling, modulation of immune cell activity, tissue protection
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tumor Necrosis Factor Receptor Type 2 (TNFR2).